Brief: Charmacy Pharmaceutical Posts FY Operating Revenue RMB4,175.28 Million
31/03/2023 14:54
March 31 (Reuters) - Charmacy Pharmaceutical Co Ltd
2289.HK :
* FY OPERATING REVENUE RMB4,175.28 MILLION, AN INCREASE OF
10.06%
* FY NET PROFIT ATTRIBUTABLE RMB90.38 MILLION, INCREASE OF
290.36%
* RECOMMENDS PAYMENT OF FINAL DIVIDEND OF RMB0.45 PER SHARE
(TAX
INCLUSIVE) FOR YEAR
Further company coverage: 2289.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Charmacy Pharmaceutical Co
See all newsBrief: Charmacy Pharmaceutical Sees Decrease In Net Profit Attributable By 45% For Year
Brief: Charmacy Pharmaceutical Says Yao Chuanglong Ceased To Be Chairman
Brief: Charmacy Pharmaceutical Posts FY Operating Revenue RMB4,175.28 Million
Brief: Charmacy Pharmaceutical Says Controlling Shareholder To Provide Loan Facility
Brief: Charmacy Pharmaceutical Says Applied For Trading Resumption From Feb 17